Key Record Dates
ClinicalTrials.gov Identifier: | NCT05498428 |
---|---|
Brief Title: | A Study of Amivantamab in Participants With Advanced or Metastatic Solid Tumors Including Epidermal Growth Factor Receptor (EGFR)-Mutated Non-Small Cell Lung Cancer (PALOMA-2) |
First Submitted : | August 10, 2022 |
First Submitted that Met QC Criteria : | August 10, 2022 |
First Posted : | August 12, 2022 |
Last Update Submitted that Met QC Criteria : | April 23, 2024 |
Last Update Posted : | April 24, 2024 |